BPDCN was previously known as CD4+ CD56+ cutaneous lymphoma, blastic natural killer cell lymphoma/leukemia, agranular CD4+ natural killer cell leukemia, and agranular CD4+ CD56+ hematodermic neoplasm [6,7,8]. This evidence concerns the gene CD4 and aggressive NK-cell leukemia.